Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in ...

The FDA expanded the approval of mirikizumab (Omvoh) to include treatment of adults with moderately to severely active ...

According to new research, wearables like an Apple Watch or an Oura smart ring can detect the symptoms and predict flare-ups ...

The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second interleukin-23p19 specific inhibitor approved for both major types of inflammatory ...

AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...

Eli Lilly and Company LLY announced that the FDA has granted approval to its drug, Omvoh (mirikizumab), for its second ...

Regularly consuming high amounts of added sugar can cause inflammation and worsen chronic conditions such as diabetes, IBD, ...

UK scientists have made a major breakthrough while investigating inflammatory bowel disease, which could change the lives of ...

Eli Lilly has received approval from the US Food and Drug Administration (FDA) for Omvoh (mirikizumab-mrkz) to treat ...

Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...